Doha, October 24 (QNA) - The Qatar Precision Health Institute (QPHI), a center for research and implementation under Qatar Foundation (QF), gathered members of Qatar's healthcare and research community for a special event to unveil groundbreaking genomic data and announce new research initiatives.

Held at Qatar Foundation's headquarters, the seminar invited leading members of Qatar's healthcare ecosystem.

Opening the event, Acting President and Chief Scientific Operations Officer at QPHI, Dr. Said Ismail highlighted the significance of the genomic data release and its impact on collaborative efforts to advance precision health.

He noted, "Today we mark a significant milestone with the release of the largest genomic dataset in Qatar and the region.

This data forms the foundation for groundbreaking research, positioning Qatar at the forefront of precision medicine.

This is not just data it's the foundation for groundbreaking research that will make Qatar a hub in genomics and translational work.

"Building on this, QPHI Lead Bioinformatician, Dr. Chadi Saad presented the 25,000 Genome Release, explaining how this new dataset will enable advancements in areas including cancer genetics, cardiovascular diseases, and mental health.

He emphasized how advanced analysis tools are being used to reduce the cost and time of research, creating new opportunities for discoveries in precision health and groundbreaking discoveries in precision health.

As part of the event's focus on advancing research access, Dr. Eleni Fthenou, Scientist at QPHI, introduced the updated data catalog.

She explained how the new platform is designed to make genomic data more accessible to researchers, streamlining the process of exploring genetic data and enabling the development of targeted treatments.

"We empower researchers, foster synergies, and listen to the needs of the academic and research community to enable them to build innovative health solutions," she said, highlighting the platform's potential to foster further collaborations and innovations in precision medicine.

Continuing the discussion, Director of Research and Partnerships at QPHI, Dr. Hamdi Mbarek announced the launch of the second round of the Qatar Precision Health Research Consortium (QPHRC).

He provided an overview of the consortium's key focus areas, including genomics of cancer, cardiovascular diseases, reproductive health, and mental health, along with genomics AI, and other strategic projects.

Dr. Mbarek emphasized QPHRC's role in bringing together researchers across institutions to tackle these critical health challenges and stated, "The consortium is designed to foster multi-institutional collaboration, bringing together experts to tackle the most pressing challenges in health.

We want to see multi-institutional and multi-disciplinary teams, which involve PhD students to build local capacity.

"These new initiatives underscore QPHI's ongoing commitment to transforming healthcare through precision medicine.

As the institute continues to collaborate with local and global partners, it is shaping the future of healthcare, driving advancements that will benefit both Qatar and the global precision medicine community. (QNA)